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Application of computational methods in drug discovery has received increased attention in recent years as a way to 
accelerate drug target prediction. Based on 443 sequence-derived protein features, we applied the most commonly 
used machine-learning methods to predict whether a protein is druggable as well as to opt for superior algorithm in 
this task[LM2]. In addition, feature selection procedures were used to provide the best performance of each classifier. 
When run on all features, Neural Network was the best classifier, with 89.98% accuracy, based on a k-fold cross-
validation test. Among all the algorithms applied, the optimum number of most-relevant features was 130, according to 
the Support Vector Machine-Random Forest (SVM-RF) algorithm. This study resulted in the discovery of new drug 
target in, among others, cell signaling pathways, gene expression, and signal transduction. The DrugMiner web tool 
was developed based on the findings of this study to provide researchers with the ability to predict druggable proteins. 
DrugMiner is freely available at www.DrugMiner.org.
Keywords: machine learning; accuracy; drug target; druggable; feature.
Introduction
Following completion of the Human Genome Project, there is the opportunity for pharmacologists to develop new 
drugs with specific targets in disease. Despite this promise, there have been few new drugs brought to market. Not 
only is the number of newly designed and approved drugs small, but their effectiveness in treating disease is also 
poor. The main reason for this is that the systems biology of most diseases is extremely complicated, making the
drug–target network intricate and difficult to navigate. Thus, it is an arduous job to design unique but efficacious
drugs for many diseases [1]. 
Analysis of the entire human genome resulted in the identification of many potential drug targets. Target-based 
drug discovery is a commonly used technique because it can reduce the costs of some laboratory experiments. 
Appropriate drug targets should have functional characteristics, such as druggability, and must be involved in 
significant biological pathways [2]. Therefore, it is crucial to continue to identify potential targets for drug design 
for the discovery of new therapeutic agents. 
A peptide, protein, or nucleic acid can be considered druggable if it interacts with a drug or nutraceutical 
molecule. Based on recent studies, most druggable proteins are classified as functional proteins (enzymes and 
hormones), ion channels, transporters, G-protein-coupled receptors (GPCRs), and nuclear receptors. Enzymes and 
GPCRs are the most significant target proteins [3] and more than half of drug targets are categorized under only 
two protein families: ‘receptors’ and ‘ion channels’. These drug targets mostly comprise GPCRs (26.8%), nuclear 
receptors (13.0%), and voltage-gated (5.5%) and ligand-gated (7.9%) ion channels [4]. 
In recent years, progress in drug discovery has benefitted from the application of computerized modeling and 
algorithms in biology, leading to the emergence of ‘computational drug discovery’ [5,6]. This term encompasses all 
areas and tools that can be applied to design and discover new drugs in complex diseases systems [7,8]. In such 
systems, drug–disease networks can be constructed to clarify how drugs affect targets in single and/or multiple 
diseases [9–11]. The high-throughput nature of computational approaches can complement the output of traditional 
experimental techniques [12]. 
Computational approaches in drug target discovery vary from statistical to machine-learning methods. For 
example, some researchers have applied functional domains and the secondary structure of proteins to analyze 











potential targets for drugs [13]. Others have analyzed binding sites to predict whether drug or drug-like compounds 
can bind on the surface of a protein according to its 3D structural properties [14,15]. These approaches depend 
heavily on the availability of protein 3D structures but, given the lack of these, their application is limited. 
Recently, machine-learning approaches have been used to predict drug target proteins. In these approaches, simple 
sequence properties, such as amino acid and di-peptide content and/or frequency, are used to predict potential 
targets [16–18]. Computationally calculated structural amino acid and/or protein features are useful because they 
can be easily calculated based on sequence and frequently predict protein function accurately [19–26]. 
In this study, we applied different machine-learning algorithms to make multi-step predictions on various 
structural and functional features of proteins. We performed a comparative analysis of machine-learning 
algorithms to determine which classifier(s) predicted druggable proteins with appropriate performance in terms of 
their accuracy, sensitivity, and specificity.
Materials and methods
Data acquisition and preparation
Prediction process needs two types of data: training and testing data. The training data set includes both positive 
(proteins that can interact with drugs) and negative (proteins that cannot be considered as drug target) samples 
[24]. The 1611 human proteins approved as drug targets and stored in the DrugBank database were retrieved (see 
Appendix 1 in the supplementary information online). Among these proteins, there were some sequences that were 
similar in terms of their sequence content and features, which resulted in misclassification and noise in prediction,
as well as increased time for algorithm implementation. To overcome these issues, similar sequences were removed. 
Finally, 1224 protein sequences were selected to comprise the positive sample set (see Appendix 1 in the 
supplementary information online). Given that there is no available database for proteins that have been 
recognized as nondrug targets, the methods proposed by Bakheet and Doig, and by Li and Lai [18,27] were used to 
establish the negative set. As a first step, human-origin protein sequences from Swiss-Prot were retrieved. Then,
all 1611 drug targets and all their related families based on sequence similarity and homology from the Pfam 
database (Pfam 27.0, March 2013, 14 831 families) were eliminated. In addition, research and experimental 
proteins known as drug targets of human origin from DrugBank [28,29], Therapeutic Target Database (TTD) [30],
and members of their related families were also omitted. To achieve a better outcome, identical records of proteins 
were also eliminated. This approach resulted in 1319 protein sequences considered as nondrug targets representing 
the negative data set (see Appendix 1 in the supplementary information online). Importantly, the proteins that 
remained [LM3]were not validated as nondrug target proteins and novel targets might still be found in this data
set. Given that only 10–15% of human proteins are druggable [31], this defeat is small [LM4]and would be unlikely 
to affect the prediction results. 
The sequences of all the proteins selected, representing 142 483 known human sequences, were retrieved from 
the Uniprot database [32] and used in the prediction algorithm. 
Attribute extraction and selection
It is well established that different attributes of proteins have a significant role in the interaction between proteins 
or between one or more drugs and a protein. These attributes vary from sequence-based features to 
physicochemical features [19,21,22,24–26,33,34]. In this study, attributes were grouped into three categories: (i) 
Group 1: physicochemical properties of protein sequences, based on amino acid values in terms of their 
physicochemical parameters, such as length, weight, hydrophobicity, alpha helix, and so on;  (ii) Group 2: amino 
acid composition, which was calculated based on the frequency of the 20 amino acid residues in the protein 
sequences; and (iii) Group 3: dipeptide composition, which was established based on the frequency of amino acid
dimers in the protein sequences (Table 1). 
There were 23, 20, and 400 attributes in groups 1, 2, and 3, respectively, all of which have the potential to affect 
the performance of an algorithm. However, the occurrence of abundant and redundant attributes leads to 
dimensionality, increasing the time for machine training and limiting the generalization of the developed model. 
For the prediction of target proteins, we tested our algorithms on single groups of attributes, different combinations
of groups, as well as on a combination of all three groups of attributes (Figure 1). Furthermore, to identify effective 
features [LM5]in the drug–protein interaction, we applied two feature selection algorithms: SVM and Relief were 
used to identify and mine the 443 attributes that were significant in distinguishing negative and positive classes. 
Classification algorithms were separately tested with an increasing number of weighed attributes by both feature 
selection algorithms to find one with the superior performance (see Appendix 2 in the supplementary information 
online).
Implemented machine-learning predictors
Here, we evaluated different machine-learning approaches to determine which one predicted drug targets with the 
highest performance. To predict whether a protein could be considered druggable, six of the most well-known 
prediction algorithms [SVM, Neural Network (NN), k-Nearest Neighborhood (kNN), Naïve Bayes, RF, and Decision 
Tree (DT)] were used to develop our predictor. The hypotheses underlying each of these algorithms were the
minimization of empirical risk and reducing the errors in the training set. Parameters of these algorithms are
summarized in Appendix 3 in the supplementary information online. These classifiers were chosen and tested with 
Orange data mining software (http://orange.biolab.si) and RapidMiner [35], as previously described [34,36]. 












A standard assessment method was essential to evaluate the performance of each algorithm. To do this, we used a 
k-fold cross-validation in which 80% of the data set was used as a training set and the remaining 20% was used as 
a test set. The performance of the algorithms was evaluated in terms of gold standards, as detailed below. These 
parameters were computed based on the values of true negatives (TN), true positives (TP), false positives (FP), and 
false negatives (FN).
Accuracy (ACC): percentage of target and nontarget proteins correctly predicted:
Sensitivity (SN): percentage of drug target proteins that were predicted correctly:
  
Specificity (SP): percentage of nontarget proteins that were correctly predicted:
Area under the curve (AUC): this parameter is a logical evaluation for model performance. Its value ranges 
from 0 to 1, where 1 represents the best performance and 0 is the worst performance. AUC = 0.5 when random 
ranking is used.
Matthews Correlation Coefficient (MCC): this value ranges from –1 for worst prediction to +1 for accurate 
prediction; zero indicates random prediction:
Precision or positive predictive value (PPV) = 
Negative predictive value (NPV) = 
F-measure: this parameter is a combined evaluation of precision and recall:
Predictor implement
Finally, the algorithm that had the best performance was selected as the predictor to be implemented over all 
available human proteins (142 483 entries) to discover which proteins could be considered as drug targets. The 
output for this step resulted in 10 091 potential targets, which are freely available at www.DrugMiner.org. 
Figure 1 summarizes the approach used her for the prediction of druggable proteins.
Target class
The gene ontology of the 10 091 proteins identified as possible drug targets was examined using the Comparative 
GO web tool [37,38].
Results 
Attribute selection
As mentioned above, the quantity and quality of attribute sets affected the classifier performance; thus, it is 
essential to select the optimum number of these attributes. Classifiers were tested with different sets of feature 
groups (see Appendix 4 in the supplementary information online for complete results). Of the seven possible group 
subsets, the subset in which all the three feature groups occurred demonstrated the best performance. Table 3 
summarizes the results for classifiers when all features were applied. 
Additionally, the SVM and Relief feature selection algorithms were used to select the optimal number of 
attributes. According to the performance of the classifiers with different numbers of features, the optimum number 
of features that were introduced by the two feature selection algorithms were 130 and 180 for SVM and Relief,
respectively (see Appendix 2 in the supplementary information online). In addition, between these two peaks, 130 
features of SVM showed the best performance. The performance of classification was evaluated after attribute 
selection. The 92.10% ACC, 92.80% sensitivity, 91.34% specificity, 84.17% (MCC), and 92.03% precision seem to be 
logical than those of 443 attributes [LM6]where these values were 89.98%, 90.14%, 89.38%, 79.82%, and 90.14%, 
respectively. Table 2 summarizes the values for the performance of the classifiers when features were weighed by 
SVM. 
Classifier selection
Six machine-learning approaches were used to develop a classifier to distinguish between target and nontarget 
proteins in the human proteome. The performance of each algorithm, using all attributes, is summarized in Table 
3. Generally, the overall ACC was dominant parameter used to observe the predictive power of a model [18]. It was 
clear that the best classification performance belonged to the NN classifier and it seemed logical to set our predictor 
based on this classifier. The feature set comprising all feature groups resulted in the best discrimination between 
target and nontarget proteins, with an accuracy of 89.78%, sensitivity of 90.14%, and specificity of 89.38% (Table 3,
Figure 2).
Target class











Gene Ontology analyses of the 10 091 predicted targets indicated that the targets belonged to protein subclasses 
that have significant roles in biological processes including cell signaling pathways, gene expression, and signal 
transduction. These proteins functionally act as enzymes, cell surface receptors, inhibitors, activators, and carriers, 
and most of the drug targets were classified as enzymes or hormones. Thus, the targets predicted by DrugMiner 
provide novel candidates that now require laboratory validation.
Discussion 
In this study, we used the six most common machine-learning algorithms to develop a prediction model for proteins 
that can be used as drug targets. The performance of each algorithm was determined by evaluating how correctly 
they could predict whether proteins were target or nontarget. The performance metrics included the rate of 
accuracy, sensitivity, and specificity of each algorithm. 
Sequence properties determine whether a protein is targetable. Generally, the application of more relevant 
attributes is key to designing a simple and functional model that has better prediction performance [33,34]. 
Previous studies related to druggable protein predictions concentrated on only a few attributes, which are unlikely 
to represent all aspects of protein–drug interactions and also have issues related to limitations of estimations and 
assumptions [17,39]. However, in this study, we increased the number of features to find the key ones, which is one 
of the reasons for the high accuracy of prediction in this study [19,23,24,26].
Among the applied algorithms, NN showed a superior performance to that of the Naïve Bayes, SVM, kNN, RF,
and DT models. More recent studies have compared approaches based on machine-learning techniques, such as RF, 
rotation forest, and SVM. However, in the current study, the performance of different classifiers was compared, and 
selected for on the basis of the best predictor of drug targets.
It is important to determine which aspects of the amino acids of a protein determines their potential as a drug 
target.. It has been proposed that the molecular function of amino acid residues has an important role in protein–
drug interaction [40]. For instance, the structures of binding sites have been analyzed more generally in terms of
their general residue preferences. There is a close link between these functional groups and DrugMiner because the 
latter was developed based on the features reported to be effective properties of residues, such as the charge of the 
protein [41–43]. Our selection proved the importance of this feature because it was ranked as a high-weighted 
feature. Many most features, including amino acid hydrophobicity, acidity, alpha helix, and the existence of sulfur 
atoms in protein structures to establish disulfide bonds, also participate in protein–drug interactions [44–46]. 
These features and their role in the druggability of proteins, guarantee the reliability of DrugMiner in the 
identification of druggable proteins because it weighed these features as pivotal features (see Appendix 2 in the 
supplementary information online).
Altogether, this study demonstrates that combination of different subsets of protein attributes and efficient 
machine-learning algorithms can remarkably improve and boost the predictability of target proteins. Thus,, results 
of this study could be used by researchers in studies of drug–protein interactions .
Concluding remarks
The application of computational approaches in the prediction of human drug targets can boost drug design and 
drug discovery. This study compared machine-learning methods running on sequence-based protein features among 
three groups of proteins to find possible targets or nontarget for drugs. Target proteins have particular features 
that govern their suitability for interactions with drugs [3,47]. Based on these characteristics, the NN classifier was 
established and used to predict potential targets for drugs among all the proteins in our study. The results showed 
that NN is efficient in predicting those proteins that are more likely to be functional as drug targets. A web tool, 
DrugMiner (www.DrugMiner.org), was developed based on the results of this study to aid researchers in predicting 
druggable proteins.
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Length, weight, half-life, alpha helix, beta sheets, isoelectric point
Aliphatic index, hydrogen, carbon, nitrogen, oxygen, sulfur
Tiny amino acids: (A, C, G, S, T)
Small amino acids: (A, C, G, S, T, V, P, D, N)
Aliphatic amino acids: (I, L, V)
Nonpolar amino acids: (A, C, G, I, L, M, P, V, Y, F, W)
Aromatic amino acids: (F, H, Y, W)
Polar amino acids: (D, H, E, Q, K, N, T, R, S)
Charged amino acids: (H, D, E, R, K)
Basic amino acids: (R, K, H)
Acidic amino acids: (D, E)
Hydrophobic amino acids: (A, C, F, I, L, M, V, Y, W)
Hydrophilic amino acids: (D, E, N, Q, K)
Group 2
b
Amino acid composition of protein sequence
Group 3c Dipeptide composition of protein sequence
a
23 features, including physicochemical properties of proteins.











b20 features, including frequency of each amino acid in protein structure.
c400 features, including frequency of dipeptides in protein structure.
Table 2. Evaluation metrics of NN using features from the SVM feature selection techniquea
FeatureNumber of 
features
SN SP MCC ACC AUC PPV FPR NPV FDR F-score
443 90.14 89.38 79.52 89.78 0.9592 90.14 10.62 89.38 9.86 90.14
430 89.92 89.87 79.77 89.89 0.9608 90.53 10.13 89.21 9.47 90.22
420 90.22 89.38 79.60 89.82 0.9606 90.15 10.62 89.45 9.85 90.19
410 90.37 89.71 80.08 90.05 0.9618 90.44 10.29 89.63 9.56 90.41
400 89.92 90.11 80.01 90.01 0.9624 90.74 9.89 89.24 9.26 90.33
390 90.75 90.11 80.86 90.44 0.9629 90.82 9.89 90.04 9.18 90.78
370 91.05 90.03 81.10 90.56 0.9643 90.78 9.97 90.33 9.22 90.92
350 90.37 90.44 80.79 90.41 0.9652 91.06 9.56 89.71 8.94 90.72
330 91.21 89.71 80.94 90.48 0.9669 90.52 10.29 90.44 9.48 90.86
310 91.13 91.01 82.13 91.07 0.9681 91.62 8.99 90.50 8.38 91.37
290 90.98 90.93 81.89 90.96 0.9698 91.53 9.07 90.34 8.47 91.25
270 91.05 90.77 81.81 90.92 0.9697 91.40 9.23 90.40 8.60 91.23
250 91.96 90.44 82.43 91.23 0.9702 91.20 9.56 91.26 8.80 91.58
230 92.27 91.01 83.30 91.66 0.9715 91.71 8.99 91.61 8.29 91.99
210 91.81 90.93 82.75 91.39 0.9709 91.60 9.07 91.15 8.40 91.71
190 92.12 90.85 82.99 91.51 0.9720 91.56 9.15 91.45 8.44 91.84
170 91.89 91.18 83.07 91.55 0.9723 91.82 8.82 91.25 8.18 91.85
150 92.42 91.01 83.46 91.74 0.9730 91.72 8.99 91.76 8.28 92.07
130 92.80 91.34 84.17 92.10 0.9728 92.03 8.66 92.17 7.97 92.41
110 92.42 91.42 83.85 91.94 0.9727 92.07 8.58 91.80 7.93 92.24
90 91.96 90.52 82.51 91.27 0.9691 91.27 9.48 91.27 8.73 91.62
70 91.05 88.89 79.99 90.01 0.9645 89.83 11.11 90.22 10.17 90.44
50 89.08 87.91 77.00 88.52 0.9579 88.81 12.09 88.20 11.19 88.95
30 85.97 85.21 71.18 85.61 0.9332 86.24 14.79 84.93 13.76 86.10
10 79.30 82.84 62.11 81.01 0.8869 83.28 17.16 78.79 16.72 81.24
a
The performance of the NN classifier with an increasing number of features ranked by the SVM feature selection. The optimum number of features was 130, where the classifier 
shows the best performance in terms of: SN (sensitivity), SP (specificity), MCC (Matthew’s correlation coefficient), ACC (accuracy), AUC (area under the curve), PPV (precision or 
positive predictive value), FPR (false positive rate). NPV (positive predictive value), and FDR (false discovery rate).
Table 3. Golden standard values for six machine-learning algorithms where all 443 protein features were applieda
Feature
Classifier
SN SP MCC ACC AUC PPV FPR NPV FDR F-score
Naïve Bayes 80.44 66.91 47.88 73.93 0.8187 72.37 33.09 76.04 27.63 76.19
KNN 88.86 80.07 69.32 84.62 0.9126 82.77 19.93 86.96 17.23 85.7
  NN 90.14 89.38 79.52 89.78 0.9592 90.14 10.62 89.38 9.86 90.14
RF 89.54 84.31 74.04 87.02 0.9444 86.02 15.69 88.21 13.98 87.74
SVM 90.07 87.83 77.94 88.99 0.9562 88.86 12.17 89.14 11.14 89.46
DT 76.72 75.08 51.8 75.93 0.7589 76.84 24.92 74.96 23.16 76.78
a
Abbreviations, NN, k-nearest neighbor; NN, neural network; RF, random forest; SVM support vector machine DT, decision tree; SN, sensitivity; SP, specificity; MCC, Matthew’s 
correlation coefficient; ACC, accuracy; AUC, area under the Curve; PPV, precision or positive predictive value; FPR, false positive rate. NPV, positive predictive value; FDR, false 
discovery rate. 
Figure 1. Illustration of the proposed approach for potential drug target prediction. Feature group 1 (G1) comprised the physicochemical properties of protein 
sequences; group 2 (G2) included amino acid composition of the proteins, and group3 (G3) involved the dipeptide composition of the proteins.
Figure 2. Area under the curve (AUC) plots of different algorithms: (A) Optimum number of features produced by support vector machine (SVM). (B) All 443 attributes.
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